NovoCure Stock Surges After FDA Approves Optune Pax

NovoCure (NASDAQ:NVCR) shares are popping on Thursday following a major FDA approval that sent the stock soaring nearly 30% in Wednesday’s after‑hours trading. NovoCure stock is showing exceptional strength. Why is NVCR stock surging? The FDA Approval Behind the...